Literature DB >> 6611114

The effect of normal aging on patterns of local cerebral glucose utilization.

D E Kuhl, E J Metter, W H Riege, R A Hawkins.   

Abstract

When the fluorine-18-labeled fluorodeoxyglucose (18FDG) scan was applied to 40 normal volunteer subjects aged 18 to 78 years, mean local cerebral metabolic rate for glucose ( lCMRGlu ) declined with advancing age at a faster rate than was reported for mean local cerebral metabolic rate for oxygen. Slopes of decline with age were similar in the centrum semiovale, caudate nucleus, putamen, and overall frontal, temporal, parietal, and occipital cortex. Superior frontal cortex and posterior inferior frontal cortex were exceptions, undergoing more rapid metabolic decline with age than in other parts of the brain. Measurements of the rate constants for transport and phosphorylation process indicate that their change with aging had no major effect on the measurement of lCMRGlu by the 18FDG method.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611114     DOI: 10.1002/ana.410150726

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  11 in total

1.  Executive dyscontrol in normal aging: normative data, factor structure, and clinical correlates.

Authors:  Donald R Royall; Laura K Chiodo; Marsha J Polk
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 5.081

2.  β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation.

Authors:  Yan Cai; Kun Xiong; Xue-Mei Zhang; Huaibin Cai; Xue-Gang Luo; Jia-Chun Feng; Richard W Clough; Robert G Struble; Peter R Patrylo; Yaping Chu; Jeffrey H Kordower; Xiao-Xin Yan
Journal:  Eur J Neurosci       Date:  2010-08-18       Impact factor: 3.386

Review 3.  Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures.

Authors:  Niall Patton; Tariq Aslam; Thomas Macgillivray; Alison Pattie; Ian J Deary; Baljean Dhillon
Journal:  J Anat       Date:  2005-04       Impact factor: 2.610

4.  CLOX: an executive clock drawing task.

Authors:  D R Royall; J A Cordes; M Polk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

5.  PET in Cerebrovascular Disease.

Authors:  William J Powers; Allyson R Zazulia
Journal:  PET Clin       Date:  2010-01-01

Review 6.  Brain metabolism in health, aging, and neurodegeneration.

Authors:  Simonetta Camandola; Mark P Mattson
Journal:  EMBO J       Date:  2017-04-24       Impact factor: 11.598

7.  The relationship of glucose-stimulated insulin secretion to cerebral glucose metabolism and cognition in healthy middle-aged and older adults.

Authors:  Gilda E Ennis; Akshay Kohli; Erin M Jonaitis; Tobey J Betthauser; Jennifer M Oh; Chase E Taylor; Nathaniel Chin; Rebecca L Koscik; Bradley T Christian; Sanjay Asthana; Sterling C Johnson; Barbara B Bendlin
Journal:  Neurobiol Aging       Date:  2021-05-06       Impact factor: 5.133

8.  IDE Gene Polymorphism Influences on BPSD in Mild Dementia of Alzheimer's Type.

Authors:  Noriko Sato; Akinori Ueki; Hideo Ueno; Hidetaka Shinjo; Yoshio Morita
Journal:  Curr Gerontol Geriatr Res       Date:  2008-12-04

9.  Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease.

Authors:  T A Pascoal; S Mathotaarachchi; S Mohades; A L Benedet; C-O Chung; M Shin; S Wang; T Beaudry; M S Kang; J-P Soucy; A Labbe; S Gauthier; P Rosa-Neto
Journal:  Mol Psychiatry       Date:  2016-03-29       Impact factor: 15.992

10.  Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease.

Authors:  Tharick A Pascoal; Sulantha Mathotaarachchi; Monica Shin; Ah Yeon Park; Sara Mohades; Andrea L Benedet; Min Su Kang; Gassan Massarweh; Jean-Paul Soucy; Serge Gauthier; Pedro Rosa-Neto
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02-02       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.